All Stories

  1. Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS outcome registry (CHRINOSOR)

    Article • World Allergy Organization Journal, April 2026, Elsevier

    Carlo Cavaliere

  2. Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSOR

    Article • Rhinology Journal, February 2026, Rhinology

    Carlo Cavaliere

  3. Real‐World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR)

    Article • Clinical and Translational Allergy, January 2026, Wiley

    Carlo Cavaliere

  4. The Oral Microbiota: Implications in Mucosal Health and Systemic Disease—Crosstalk with Gut and Brain

    Article • Cells, January 2026, MDPI AG

    Carlo Cavaliere

  5. Evaluation of the Antihistamine and Anti-Inflammatory Effects of a Nutraceutical Blend Based on Quercetin, Perilla frutescens, Boswellia serrata, Blackcurrant, Parthenium, Helichrysum, Lactobacillus acidophilus and Bifidobacterium animalis Through In V...

    Article • Current Issues in Molecular Biology, November 2025, MDPI AG

    Carlo Cavaliere

  6. Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL Population

    Article • Clinical Otolaryngology, November 2025, Wiley

    Carlo Cavaliere

  7. Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events

    Article • The Journal of Allergy and Clinical Immunology In Practice, October 2025, Elsevier

    Carlo Cavaliere

  8. Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR)

    Article • Clinical and Translational Allergy, August 2025, Wiley

    Carlo Cavaliere

  9. Two‐Year Turning Point With Dupilumab in CRSwNP: Control, Remission, and Tapering Dosage

    Article • Allergy, August 2025, Wiley

    Carlo Cavaliere

  10. Remission in chronic rhinosinusitis with nasal polyps treated with biologics: a real-life experience

    Article • European Archives of Oto-Rhino-Laryngology, August 2025, Springer Science + Business Media

    Carlo Cavaliere

  11. Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review

    Article • Current Allergy and Asthma Reports, July 2025, Springer Science + Business Media

    Carlo Cavaliere

  12. Patient-Specific Factors to Differentiate Between Branchial Cleft Cysts and CUP Syndrome: A 10 Year Unicenter Study

    Article • Ear Nose & Throat Journal, May 2025, SAGE Publications

    Carlo Cavaliere

  13. Defining two dimensional transthoracic echocardiographic aorta dimension reference ranges in healthy subjects: a machine learning based model

    Article • European Journal of Preventive Cardiology, May 2025, Oxford University Press (OUP)

    Professor Filippo Cademartiri, Carlo Cavaliere

  14. The Emerging Role of MicroRNAs in Nasal Inflammatory Diseases and Tumors: From Bench to Bedside

    Article • Genes, February 2025, MDPI AG

    Carlo Cavaliere

  15. Pilot Study on the Efficacy of a Novel Questionnaire for Assessing Psychological Health in Patients with Chronic Rhinosinusitis with Nasal Polyps Treated with Biologics

    Article • Healthcare, February 2025, MDPI AG

    Carlo Cavaliere

  16. Narrative Review of Genetic and Immunological Mechanisms Involved in the Pathogenesis of Kimura’s Disease: New Therapeutic Targets

    Article • Genes, February 2025, MDPI AG

    Carlo Cavaliere

  17. Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR)

    Article • Journal of Allergy and Clinical Immunology, February 2025, Elsevier

    Carlo Cavaliere

  18. Pre-biologic FeNO might predict anti-IL-5/IL-5Rα response to treatment in severe asthmatics

    Article • Journal of Asthma, January 2025, Taylor & Francis

    Carlo Cavaliere

  19. Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR)

    Article • Rhinology Journal, January 2025, Rhinology

    Carlo Cavaliere

  20. Allergic Rhinitis in Professional Singers: A Monoinstitutional Series

    Article • Journal of Voice, October 2024, Elsevier

    Carlo Cavaliere

  21. Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab

    Article • European Archives of Oto-Rhino-Laryngology, September 2024, Springer Science + Business Media

    Carlo Cavaliere

  22. Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study

    Article • Journal of Clinical Medicine, June 2024, MDPI AG

    Carlo Cavaliere

  23. Kurzfristige Lebensqualitätsbewertung nach Nasennebenhöhlenoperation bei chronischer Rhinosinusitis

    Article • Laryngo-Rhino-Otologie, May 2024, Thieme Publishing Group

    Carlo Cavaliere

  24. Open-door extended endoscopic transorbital technique to the paramedian anterior and middle cranial fossae: technical notes, anatomomorphometric quantitative analysis, and illustrative case

    Article • Neurosurgical FOCUS, April 2024, Journal of Neurosurgery Publishing Group (JNSPG)

    Carlo Cavaliere

  25. Long-Term Perspectives on Chronic Rhinosinusitis with Nasal Polyps: Evaluating Recurrence Rates after Functional Endoscopic Sinus Surgery in the Biologics Era—A 5-Year Follow-Up Study

    Article • Journal of Personalized Medicine, March 2024, MDPI AG

    Carlo Cavaliere

  26. Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)

    Article • Current Allergy and Asthma Reports, March 2024, Springer Science + Business Media

    Carlo Cavaliere

  27. Perceptual, aerodynamic and acoustic outcomes of surgical technique for sulcus vocalis patients: A systematic review and meta analysis

    Article • American Journal of Otolaryngology, March 2024, Elsevier

    Carlo Cavaliere

  28. TIVA and TCI in Modern Anesthesia

    Article • January 2024, Springer Science + Business Media

    Carlo Cavaliere

  29. Normative data for interpreting the SNOT-22

    Article • Acta Otorhinolaryngologica Italica, December 2023, Pacini Editore

    Carlo Cavaliere

  30. The Impact of Antibiotics and Steroids on the Nasal Microbiome in Patients with Chronic Rhinosinusitis: A Systematic Review According to PICO Criteria

    Article • Journal of Personalized Medicine, November 2023, MDPI AG

    Carlo Cavaliere

  31. Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice

    Article • Journal of Personalized Medicine, October 2023, MDPI AG

    Carlo Cavaliere

  32. High-Definition 3D Exoscope in Pediatric Otorhinolaryngology: A Systematic Literature Review

    Article • Journal of Clinical Medicine, October 2023, MDPI AG

    Carlo Cavaliere

  33. Impatto della pandemia COVID-19 sull’otorinolaringoiatria pediatrica

    Article • Acta Otorhinolaryngologica Italica, October 2023, Pacini Editore

    Carlo Cavaliere

  34. Raccomandazioni pratiche nella gestione ambulatoriale della rinosinusite cronica con poliposi nasale severa, nell’era dei biologici

    Article • Acta Otorhinolaryngologica Italica, October 2023, Pacini Editore

    Carlo Cavaliere

  35. Diagnostic therapeutic assistance pathway (PDTA) of type 2 chronic rhinosinusitis

    Article • Frontiers in Allergy, September 2023, Frontiers

    Carlo Cavaliere

  36. Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life

    Article • Journal of Immunology Research, September 2023, Hindawi Publishing Corporation

    Carlo Cavaliere

  37. Normative values of the topological metrics of the structural connectome: A multi-site reproducibility study across the Italian Neuroscience network

    Article • Physica Medica, August 2023, Elsevier

    Carlo Cavaliere

  38. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)

    Article • Allergy, May 2023, Wiley

    Carlo Cavaliere

  39. Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts

    Article • Journal of Clinical Medicine, April 2023, MDPI AG

    Carlo Cavaliere

  40. Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?

    Article • Annals of Allergy Asthma & Immunology, April 2023, Elsevier

    Carlo Cavaliere

  41. La gestione del paziente con rinosinusite cronica e poliposi nasale in Italia: expert opinion sul percorso diagnostico-terapeutico

    Article • AboutOpen, March 2023, Aboutscience Srl

    Carlo Cavaliere

  42. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

    Article • International Forum of Allergy & Rhinology, March 2023, Wiley

    Professor Adnan Custovic, Carlo Cavaliere

  43. Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology

    Article • The Journal of Allergy and Clinical Immunology In Practice, February 2023, Elsevier

    Carlo Cavaliere

  44. Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?

    Article • Life, January 2023, MDPI AG

    MD, PhD Arianna Di Stadio, Carlo Cavaliere

  45. Does a closed reduction improve aesthetical and functional outcome after nasal fracture?

    Article • European Archives of Oto-Rhino-Laryngology, November 2022, Springer Science + Business Media

    Carlo Cavaliere

  46. Systematic Review of Parotid Gland Sarcomas: Multi-Variate Analysis of Clinicopathologic Findings, Therapeutic Approaches and Oncological Outcomes That Affect Survival Rate

    Article • Cancers, October 2022, MDPI AG

    MD, PhD Arianna Di Stadio, Carlo Cavaliere

  47. Effects of the Silica Dust on the Nasal Mucosa of Ceramic Workers

    Article • Sustainability, October 2022, MDPI AG

    Carlo Cavaliere

  48. Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.

    Article • Immunology Letters, August 2022, Elsevier

    Carlo Cavaliere

  49. The Role of Allergen-Specific Immunotherapy in ENT Diseases: A Systematic Review

    Article • Journal of Personalized Medicine, June 2022, MDPI AG

    Carlo Cavaliere

  50. Reboot surgery for chronic rhinosinusitis with nasal polyposis: recurrence and smell kinetics

    Article • European Archives of Oto-Rhino-Laryngology, June 2022, Springer Science + Business Media

    Carlo Cavaliere

  51. Long-term outcomes and quality of life following parotidectomy for benign disease

    Article • Acta Otorhinolaryngologica Italica, June 2022, Pacini Editore

    Carlo Cavaliere

  52. Survey on Use of Local and Systemic Corticosteroids in the Management of Chronic Rhinosinusitis with Nasal Polyps: Identification of Unmet Clinical Needs

    Article • Journal of Personalized Medicine, May 2022, MDPI AG

    Carlo Cavaliere

  53. The Present and Future of Allergen Immunotherapy in Personalized Medicine

    Article • Journal of Personalized Medicine, May 2022, MDPI AG

    Carlo Cavaliere

  54. Quantitative MRI Harmonization to Maximize Clinical Impact: The RIN–Neuroimaging Network

    Article • Frontiers in Neurology, April 2022, Frontiers

    Carlo Cavaliere

  55. Advances in chronic rhinosinusitis in 2020 and 2021

    Article • Journal of Allergy and Clinical Immunology, March 2022, Elsevier

    Carlo Cavaliere

  56. Long-Term Subjective and Objective Assessment of Smell and Taste in COVID-19

    Article • Cells, February 2022, MDPI AG

    Carlo Cavaliere

  57. Correlation between olfactory function, age, sex, and cognitive reserve index in the Italian population

    Article • European Archives of Oto-Rhino-Laryngology, February 2022, Springer Science + Business Media

    Carlo Cavaliere

  58. Sensitization to Gibberellin-Regulated Protein (Peamaclein) Among Italian Cypress Pollen–Sensitized Patients

    Article • Journal of Investigational Allergology and Clinical Immunology, February 2022, Esmon Publicidad, SA

    Carlo Cavaliere

  59. Ceramic Workers and the Inflammatory Effects of the Silica Dust on the Nasal Mucosa Detected by Nasal Cytology: a Pilot Study

    Article • January 2022, Research Square

    Carlo Cavaliere

  60. Perioperative Management of Patients Affected by Ischemic Cardiomyopathy

    Article • January 2022, Springer Science + Business Media

    Carlo Cavaliere

  61. Allergen Immunotherapy management during vaccinations: An international survey

    Article • World Allergy Organization Journal, November 2021, Elsevier

    Dr Giorgio Ciprandi, Carlo Cavaliere

  62. Bilateral and Ipsilateral Central Neck Dissection in Total Thyroidectomy: a Long Term Comparison of Complications

    Article • Indian Journal of Otolaryngology and Head & Neck Surgery, October 2021, Springer Science + Business Media

    Carlo Cavaliere

  63. Nasal cytology identifies allergic rhinitis phenotypes for managing allergen immunotherapy in clinical practice

    Article • Allergo Journal International, September 2021, Springer Science + Business Media

    Carlo Cavaliere

  64. Diagnostic performance of nasal cytology

    Article • European Archives of Oto-Rhino-Laryngology, August 2021, Springer Science + Business Media

    Carlo Cavaliere

  65. How to predict the outcome of septorhinoplasty? A normative study of ROE and FROI-17 scores

    Article • Acta Otorhinolaryngologica Italica, August 2021, Pacini Editore

    Carlo Cavaliere

  66. Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis

    Article • Annals of Allergy Asthma & Immunology, April 2021, Elsevier

    Carlo Cavaliere

  67. The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?

    Article • Expert Opinion on Drug Safety, January 2021, Taylor & Francis

    Carlo Cavaliere

  68. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management

    Article • Journal of Allergy and Clinical Immunology, January 2021, Elsevier

    Carlo Cavaliere

  69. Long-term omalizumab efficacy in allergic rhinitis

    Article • Immunology Letters, November 2020, Elsevier

    Carlo Cavaliere

  70. Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis

    Article • Respiratory Medicine and Research, November 2020, Elsevier

    Carlo Cavaliere

  71. Mepolizumab Effectiveness and Allergic Status in Real Life

    Article • International Archives of Allergy and Immunology, October 2020, Karger Publishers

    Carlo Cavaliere

  72. Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction

    Article • International Journal of Cardiology, October 2020, Elsevier

    Carlo Cavaliere

  73. Diagnosis of Obstructive Sleep Apnea in Patients with Allergic and Non-Allergic Rhinitis

    Article • Medicina, September 2020, MDPI AG

    Carlo Cavaliere

  74. The role of allergoids in allergen immunotherapy: from injective to sublingual route

    Article • European Annals of Allergy and Clinical Immunology, September 2020, Edra SpA

    Carlo Cavaliere

  75. Eosinophilic lingual tonsillitis induced by sublingual immunotherapy: A case series

    Article • Clinical Case Reports, August 2020, Wiley

    Carlo Cavaliere

  76. Role of invariant natural killer t cells in patients with tonsillar hypertrophy: the tonsil as an immunological organ.

    Article • June 2020, Asia Pacific Academy of Science Pte. Ltd.

    Carlo Cavaliere

  77. Effects of paraprobiotic MIMLh5 in the treatment of chronic rhinopharyngitis

    Article • Otorinolaringologia, June 2020, Edizioni Minerva Medica

    Carlo Cavaliere

  78. Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications

    Article • The Journal of Allergy and Clinical Immunology In Practice, May 2020, Elsevier

    Carlo Cavaliere

  79. Biologics for chronic rhinosinusitis with nasal polyps

    Article • Journal of Allergy and Clinical Immunology, March 2020, Elsevier

    Carlo Cavaliere

  80. Total Versus Completion Thyroidectomy: A Multidimensional Evaluation of Long-Term Vocal Alterations

    Article • Ear Nose & Throat Journal, December 2019, SAGE Publications

    Carlo Cavaliere

  81. The spectrum of therapeutic activity of mepolizumab

    Article • Expert Review of Clinical Immunology, August 2019, Taylor & Francis

    Carlo Cavaliere, Eleni Makri

  82. Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes

    Article • The Journal of Allergy and Clinical Immunology In Practice, May 2019, Elsevier

    Alberto Cresti, Carlo Cavaliere

  83. Size and shape of the inferior vena cava before and after a fluid challenge: a pilot study

    Article • Minerva Anestesiologica, April 2019, Edizioni Minerva Medica

    Carlo Cavaliere

  84. Recovery of smell sense loss by mepolizumab in a patient allergic to Dermatophagoides and affected by chronic rhinosinusitis with nasal polyps

    Article • Clinical and Molecular Allergy, February 2019, Springer Science + Business Media

    Carlo Cavaliere

  85. Postoperative Pain Management

    Article • January 2019, Springer Science + Business Media

    Carlo Cavaliere

  86. Changes of NGF pathway in allergic rhinoconjunctivitis: A conjunctival allergen challenge study

    Article • Allergy, November 2018, Wiley

    Carlo Cavaliere

  87. Therapeutic Applications of Capsaicin in Upper Airways

    Article • Current Drug Targets, July 2018, Bentham Science Publishers

    Carlo Cavaliere, Franco Cavaliere

  88. Factors reducing omalizumab response in severe asthma

    Article • European Journal of Internal Medicine, June 2018, Elsevier

    Alberto Cresti, Carlo Cavaliere

  89. Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma

    Article • Journal of Investigational Allergology and Clinical Immunology, December 2017, Esmon Publicidad, SA

    Alberto Cresti, Carlo Cavaliere

  90. Atrial Fibrillation in the Perioperative Period

    Article • November 2017, Springer Science + Business Media

    Carlo Cavaliere

  91. Relationship Between Autism And Nasal Cytology

    Article • IOSR Journal of Dental and Medical Sciences, April 2017, IOSR Journals

    Carlo Cavaliere

  92. A survey on features of allergic rhinitis in children

    Article • Current Medical Research and Opinion, March 2013, Taylor & Francis

    Carlo Cavaliere

  93. Characteristics of Candidates for Allergen Immunotherapy

    Article • Allergy & Rhinology, January 2013, SAGE Publications

    Dr Giorgio Ciprandi, Carlo Cavaliere

  94. Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy

    Article • Drug Design Development and Therapy, May 2012, Taylor & Francis

    Carlo Cavaliere

  95. maxon motor launches innovative 040 mm,150 watt high power DC motor

    Article • Aircraft Engineering, June 2000, Emerald

    Carlo Cavaliere